You are here: Industry Insights > SARS-CoV-2

News List

COVID-19 containment shaped by strength, duration of natural, vaccine-induced immunity worldpharmanews
October 28, 2020
"Much of the discussion so far related to the future trajectory of COVID-19 has rightly been focused on the effects of seasonality and non-pharmaceutical interventions [NPIs], such as mask-wearing and physical distancing," said co-first author ...
Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark prnasia
October 28, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU.
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs pharmatimes
October 26, 2020
German pharma company Merck KGaA has partnered with non-profit scientific research organisation IAVI and Serum Institute of India to develop monoclonal antibodies (mAbs) for COVID-19.
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay americanpharmaceuticalreview
October 26, 2020
Beroni Group has announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation. The assay targets on coronavirus-specific nanobodies and tests affinity and efficacy to prevent the ...
A vaccine project funded by the Federal Ministry for Economic Affairs and Energy develops a second generation COVID-19 vaccine worldpharmanews
October 23, 2020
A vaccine project funded by the EXIST programme initiated by the Federal Ministry for Economic Affairs and Energy (Germany) is developing a second generation Covid-19 vaccine.
Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds worldpharmanews
October 23, 2020
The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety.
Centogene Receives EUA for SARS-CoV-2 RT-PCR Assay americanpharmaceuticalreview
October 23, 2020
Centogene announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for CentoSure, the company's latest SARS-CoV-2 RT-PCR test.
DxTerity Announces New At-Home COVID-19 Testing Solution americanpharmaceuticalreview
October 23, 2020
DxTerity Diagnostics announced the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA 202120) for their SARS-CoV-2 RT-PCR test, SafeWorkDx™.
Aridis Reports Positive Preclinical Efficacy Data for Inhaled Treatment for COVID-19 americanpharmaceuticalreview
October 23, 2020
Aridis Pharmaceuticals announced the development of a highly neutralizing monoclonal antibody AR-711, discovered from convalescent COVID-19 patients that successfully eliminated all detectable SARS-CoV-2 virus in infected animals at ...
EIB to support COVID-19 therapy with €24.5 million investment europeanpharmaceuticalreview
October 22, 2020
The European Investment Bank (EIB) will provide Immunic with up to €24.5 million to support the ongoing development of IMU-838, a potential COVID-19 therapy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page